Insmed to Present at Two March Conferences

Insmed announces participation in two virtual investor conferences.

Rhea-AI Summary

Insmed announces participation in two virtual investor conferences. The company will present at the Cowen 41st Annual Health Care Conference on March 3, 2021, at 11:40 a.m. ET, and at the H.C. Wainwright Global Life Sciences Conference on March 9, 2021, at 7:00 a.m. ET. Webcasts of both events will be available on Insmed's investor relations website and archived for 30 days. Insmed focuses on developing therapies for serious and rare diseases, with its first commercial product approved for a chronic lung disease.

Argus Session date unavailable

+1.88% session move Open Argus

Details

News Market Reaction – INSM

The recorded move for INSM in the trading session of this news was +1.88%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BRIDGEWATER, N.J., Feb. 24, 2021 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will participate in the following virtual investor events:

• The Cowen 41^st Annual Health Care Conference on Wednesday, March 3, 2021 at 11:40 a.m. ET

• The H.C. Wainwright Global Life Sciences Conference on Tuesday, March 9, 2021 at 7:00 a.m. ET

Each fireside chat will be webcast and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Each webcast will be archived for a period of 30 days following the conclusion of each live event.

About Insmed

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States and the European Union to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing footprint across Europe and in Japan. For more information, visit www.insmed.com.

Contact:

Investors:

Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com

Media:

Mandy Fahey
Senior Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/insmed-to-present-at-two-march-conferences-301233968.html

SOURCE Insmed Incorporated

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What conferences is Insmed (INSM) participating in March 2021?

Insmed will participate in the Cowen 41st Annual Health Care Conference on March 3, 2021, and the H.C. Wainwright Global Life Sciences Conference on March 9, 2021.

What is the date and time of Insmed's presentation at the Cowen Conference?

Insmed's presentation at the Cowen Conference is scheduled for March 3, 2021, at 11:40 a.m. ET.

How can I access the webcasts of Insmed's presentations?

Webcasts of Insmed's presentations can be accessed on their investor relations website and will be archived for 30 days.

What is the focus of Insmed's product pipeline?

Insmed's product pipeline targets serious unmet needs, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders.

Where is Insmed headquartered?

Insmed is headquartered in Bridgewater, New Jersey.